Diagnosis and Treatment of Post-Traumatic Stress Disorder (PTSD)
For patients presenting with symptoms of PTSD, trauma-focused psychotherapy (such as prolonged exposure therapy, cognitive processing therapy, or EMDR) should be initiated as first-line treatment, with SSRIs (sertraline 50-200 mg/day or paroxetine 20-60 mg/day) recommended as pharmacological options. 1
Diagnostic Approach
Diagnostic Criteria
- PTSD diagnosis requires symptoms to persist for more than 3 months following exposure to a traumatic event 1
- Five symptom domains must be present:
- Exposure to actual or threatened death, serious injury, or sexual violence
- Intrusion symptoms (recurrent distressing memories, flashbacks, dreams)
- Avoidance of trauma-related stimuli
- Negative alterations in cognitions and mood
- Marked alterations in arousal and reactivity 1
Assessment Tools
- Use standardized measures such as the PTSD Checklist for DSM-5 (PCL-5) to track symptoms weekly 1
- The PCL-5 can be divided into subscores corresponding to the three main symptom clusters: reexperiencing, avoidance, and hyperarousal 2
Differential Diagnosis
- Consider Complex PTSD (recognized in ICD but not in DSM-5) 1
- Rule out adjustment disorder, acute stress disorder, major depressive disorder, anxiety disorders, and substance-induced disorders 1
- For symptoms present less than 30 days after trauma, consider posttraumatic stress syndrome (PTSS) 3
Treatment Approach
First-Line Treatments
Trauma-Focused Psychotherapy
Pharmacotherapy
- First-line medications:
- Continue effective medication for at least 6-12 months to decrease relapse rates 1
Treatment Algorithm
Initial Approach:
- Begin trauma-focused psychotherapy as first-line treatment
- Consider adding SSRI (sertraline or paroxetine) concurrently, especially with severe symptoms or comorbid depression
If inadequate response after 8-12 weeks:
- Switch to alternative trauma-focused therapy approach
- Adjust medication dose if using pharmacotherapy
- Consider combination therapy if using only one modality
For residual symptoms:
- Consider adjunctive treatments for specific symptoms (e.g., prazosin for nightmares) 8
- Evaluate for comorbid conditions that may require targeted treatment
Special Considerations
Sleep Disturbances
- Sleep problems are common in PTSD due to hyperarousal or nightmares
- Consider screening for obstructive sleep apnea 8
- Prazosin may be effective for PTSD-related sleep disturbance 8
Medications to Avoid
- Benzodiazepines are not recommended for PTSD treatment as they may worsen outcomes 1
Comorbidities
- Psychiatric comorbidities, particularly mood disorders and substance use, are common in PTSD 8
- Treat comorbid conditions concurrently for best outcomes
Long-Term Management
- Monitor progress using standardized PTSD measures (PCL-5) 1
- Continue effective treatment for at least 6-12 months 1
- Periodically re-evaluate the need for ongoing treatment 6, 7
Treatment Efficacy
- Trauma-focused psychotherapies have demonstrated stronger treatment effects compared to pharmacological interventions 9
- SSRIs have shown modest but significant effects in reducing PTSD symptoms 9
- In clinical trials, 53-85% of participants using SSRIs were classified as treatment responders 1
Remember that early recognition and intervention may help reduce the severity and chronicity of PTSD symptoms, potentially preventing progression to chronic PTSD 3.